PMC-402


Indications: Solid tumors


PMC-402 is a monoclonal antibody that targets the human Tie2 that regulated activation, proliferation, and repolarization of Tie2 expressing macrophages, resulting in T cell activation.


Mechanism of action / Target

PMC-402 binds to TIE2 expressing macrophages that activate T cells in the tumor microenvironment (TME).


Status

An increase in T cell activity along with a shift in polarization from M2 to M1 macrophages have been identified in the in vitro study. The production of samples needed for the GLP-Toxicity study is underway for the IND filing.


LinkedIn  I   Facebook  I  YouTube



    • 2F, Research Building 2, 70, Yuseong-daero 1689 beon-gil,
      Yuseong-gu, Daejeon, 34047, Republic of Korea
    • HQ +82-42-863-2017
    • R&D Center +82-42-861-2017
    • FAX +82-42-863-2080
  • COPYRIGHT BY PharmAbcine Inc. ALL RIGHTS RESERVED.